MarketBeat Instant News Alerts 2 hours agoNewAmsterdam Pharma Maps Obicetrapib Strategy as PREVAIL Interim NearsMarketBeatNewAmsterdam Pharma (NASDAQ:NAMS) used its annual Investor Day to outline its cardiovascular outcomes strategy for obicetrapib, provide updates on additional clinical programs and discuss commercial preparations ahead of a potential European launch. Chief Executive Officer Michael Davidson said theNASDAQ:NAMSRead NewAmsterdam Pharma Maps Obicetrapib Strategy as PREVAIL Interim Nears2 hours agoMedline Q2 Earnings Call HighlightsMarketBeatMedline (NASDAQ:MDLN) reported second-quarter 2026 net sales growth of 12% to $7.7 billion, supported by demand across its medical-surgical product and supply-chain businesses, while raising its full-year organic sales outlook. The company also lowered its adjusted EBITDA guidance, citing operationaNASDAQ:MDLNRead Medline Q2 Earnings Call Highlights2 hours agoLimbach Q2 Earnings Call HighlightsMarketBeatLimbach (NASDAQ:LMB) reported second-quarter 2026 results that fell short of management’s expectations as project timing, healthcare and institutional-market softness, and margin pressure weighed on profitability. The company also announced the acquisition of data center program manager CYMCOR for $NASDAQ:LMBRead Limbach Q2 Earnings Call Highlights2 hours agoLivaNova Q2 Earnings Call HighlightsMarketBeatLivaNova (NASDAQ:LIVN) reported record quarterly revenue and adjusted earnings per share for the second quarter of 2026, citing double-digit reported growth across its Cardiopulmonary and Epilepsy businesses. The company raised its full-year revenue and adjusted EPS outlook while reducing its adjustNASDAQ:LIVNRead LivaNova Q2 Earnings Call Highlights2 hours agoLineage Q2 Earnings Call HighlightsMarketBeatLineage (NASDAQ:LINE) reported second-quarter results that exceeded its internal expectations and consensus estimates as warehouse occupancy improved and cost-control efforts helped offset continued trade-related volume pressure. Adjusted EBITDA totaled approximately $320 million for the quarter, wNASDAQ:LINERead Lineage Q2 Earnings Call Highlights2 hours agoKymera Therapeutics Q2 Earnings Call HighlightsMarketBeatKymera Therapeutics (NASDAQ:KYMR) said it completed enrollment in its Phase 2b atopic dermatitis trial of KT-621 about six months ahead of schedule, positioning the company to report top-line data by the end of 2026 and potentially begin Phase 3 development around mid-2027. Chief Executive Officer NASDAQ:KYMRRead Kymera Therapeutics Q2 Earnings Call Highlights Trending News1Tilray Brands (NASDAQ:TLRY) Rating Increased to Strong-Buy at TD Securities2BlackBerry Limited $BB Shares Purchased by Renaissance Technologies LLC3Archer Aviation (ACHR) Projected to Announce Quarterly Earnings on Monday4Rocket Lab (RKLB) to Post Quarterly Earnings on Monday5Northland Securities Predicts BigBear.ai Q1 Earnings6Plug Power (PLUG) Expected to Release Quarterly Earnings on Monday7Alphabet (NASDAQ:GOOG) Stock Price Up 6.9% - Should You Buy?8Advanced Micro Devices Q2 Earnings Call Highlights All MarketBeat Instant News Alerts Latest News Trending News Sort By Last 24 Hours Last 3 Days Last 5 Days Last 7 Days Last 14 Days Last 30 Days Last 90 Days All Time Time Frame All Alerts Analyst Congressional Trades Consensus Corporate Buyback Corporate Event Transcript Dividend Earnings Earnings Preview Earnings Transcript Highlights Estimates Guidance Insider Trade Lockup Expiration MarketBeat List Articles Options Price SEC Filing Stock List Stock Split Alert Type Keywords 2 hours agoJ & J Snack Foods Q3 Earnings Call HighlightsMarketBeatNASDAQ:JJSFRead J & J Snack Foods Q3 Earnings Call Highlights2 hours agoInterparfums Q2 Earnings Call HighlightsMarketBeatNASDAQ:IPARRead Interparfums Q2 Earnings Call Highlights2 hours agoPromising Outdoor Stocks To Consider - August 5thMarketBeatNYSE:TREXRead Promising Outdoor Stocks To Consider - August 5th2 hours agoTop Oil Stocks To Research - August 5thMarketBeatNYSE:XOMRead Top Oil Stocks To Research - August 5th2 hours agoCorVel Q1 Earnings Call HighlightsMarketBeatNASDAQ:CRVLRead CorVel Q1 Earnings Call Highlights2 hours agoNuclear Stocks To Follow Now - August 5thMarketBeatNYSE:OKLORead Nuclear Stocks To Follow Now - August 5th2 hours agoMining Stocks To Keep An Eye On - August 5thMarketBeatNYSE:CATRead Mining Stocks To Keep An Eye On - August 5th2 hours agoTop Medical Stocks To Research - August 5thMarketBeatNASDAQ:GILDRead Top Medical Stocks To Research - August 5th2 hours agoAvnet Q4 Earnings Call HighlightsMarketBeatNASDAQ:AVTRead Avnet Q4 Earnings Call Highlights2 hours agoPromising Industrial Stocks To Research - August 5thMarketBeatNYSE:UBERRead Promising Industrial Stocks To Research - August 5th2 hours agoBest Hotel Stocks To Add to Your Watchlist - August 5thMarketBeatNASDAQ:BKNGRead Best Hotel Stocks To Add to Your Watchlist - August 5th2 hours agoTop Hydrogen Stocks To Follow Now - August 5thMarketBeatNYSE:SMRRead Top Hydrogen Stocks To Follow Now - August 5th2 hours agoBest Healthcare Stocks Worth Watching - August 5thMarketBeatNYSE:LLYRead Best Healthcare Stocks Worth Watching - August 5th2 hours agoBest Growth Stocks To Consider - August 5thMarketBeatNYSE:PLDRead Best Growth Stocks To Consider - August 5th2 hours agoPromising Gold Stocks Worth Watching - August 5thMarketBeatNYSE:FCXRead Promising Gold Stocks Worth Watching - August 5th2 hours agoTeledyne Technologies (NYSE:TDY) Reaches New 52-Week High - What's Next?MarketBeatNYSE:TDYRead Teledyne Technologies (NYSE:TDY) Reaches New 52-Week High - What's Next?2 hours agoDucommun (NYSE:DCO) Sets New 12-Month High - Here's What HappenedMarketBeatNYSE:DCORead Ducommun (NYSE:DCO) Sets New 12-Month High - Here's What Happened2 hours agoCelanese (NYSE:CE) Trading Down 6.3% - Should You Sell?MarketBeatNYSE:CERead Celanese (NYSE:CE) Trading Down 6.3% - Should You Sell?2 hours agoGXO Logistics (NYSE:GXO) Stock Price Down 6.5% - Should You Sell?MarketBeatNYSE:GXORead GXO Logistics (NYSE:GXO) Stock Price Down 6.5% - Should You Sell?2 hours agoDigitalOcean (NYSE:DOCN) Shares Down 6.5% - Time to Sell?MarketBeatNYSE:DOCNRead DigitalOcean (NYSE:DOCN) Shares Down 6.5% - Time to Sell?2 hours agoShionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY) Trading Down 6.9% - Here's WhyMarketBeatOTCMKTS:SGIOYRead Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY) Trading Down 6.9% - Here's Why2 hours agoEnlight Renewable Energy (NASDAQ:ENLT) Stock Price Down 7.1% - Should You Sell?MarketBeatNASDAQ:ENLTRead Enlight Renewable Energy (NASDAQ:ENLT) Stock Price Down 7.1% - Should You Sell?2 hours agoPACS Group (NYSE:PACS) Trading Down 8% - Should You Sell?MarketBeatNYSE:PACSRead PACS Group (NYSE:PACS) Trading Down 8% - Should You Sell?2 hours agoEVE (NYSE:EVEX) Stock Price Down 8.4% - Time to Sell?MarketBeatNYSE:EVEXRead EVE (NYSE:EVEX) Stock Price Down 8.4% - Time to Sell? Featured Articles and OffersWhy SK hynix Could Be the Best AI Chip Stock to Buy NowBy Thomas Hughes | July 29, 2026Ready to give options a try? Your first trade (Ticker included) -INSIDEFrom Base Camp Trading (Ad)SpaceX’s First Earnings Report Could Decide Whether Shorts or Bulls Have ControlBy Jeffrey Neal Johnson | August 3, 20263 Fixed-Income ETFs Show Why Yield Is Only Part of the Income StoryBy Nathan Reiff | August 2, 2026System Upgrade: First Internet Bancorp Options SurgeBy Jeffrey Neal Johnson | August 4, 2026NNVC Gets FDA Boost While Analyst Targets $6.00!From Equiscreen (Ad)Tilray Brands (NASDAQ:TLRY) Rating Increased to Strong-Buy at TD SecuritiesBy MarketBeat | August 1, 2026Microsoft Just Flipped the AI Spending Narrative OvernightBy Chris Markoch | July 30, 2026 Alert CategoriesAll AlertsAnalystCongressional TradesConsensusCorporate BuybackCorporate Event TranscriptStock ListDividendEarningsEarnings PreviewEarnings Transcript HighlightsEstimatesGuidanceInsider TradeLockup ExpirationMarketBeat List ArticlesOptionsPriceSEC FilingStock Split Page 1 of 509 1234567 Earlier › Earliest » Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
